Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy

European Urology

Volumn 64, Issue 3, 2013, Pages 456-464

  Rink, Michael ^a,b   Zabor, Emily C ^c   Furberg, Helena ^c   Xylinas, Evanguelos ^a,d   Ehdaie, Behfar ^a   Novara, Giacomo ^e   Babjuk, Marko ^f   Pycha, Armin ^g   Lotan, Yair ^h   Trinh, Quoc Dien ⁱ   Chun, Felix K ^b   Lee, Richard K ^a   Karakiewicz, Pierre I ⁱ   Fisch, Margit ^b   Robinson, Brian D ^a,j   Scherr, Douglas S ^a   Shariat, Shahrokh F ^a,j  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d Paris Descartes University ^*  (France)

^e UNIVERSITY OF PADOVA   (Italy)

^f UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^g CENTRAL HOSPITAL OF BOLZANO   (Italy)

^h UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

ⁱ UNIVERSITÉ DE MONTRÉAL   (Canada)

^j NEW YORK PRESBYTERIAN HOSPITAL   (United States)

more..

Author keywords

Dose response; Muscle invasive bladder cancer; Progression; Radical cystectomy; Recurrence; Smoking; Survival; Urothelial carcinoma

Indexed keywords

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; COHORT ANALYSIS; CONTROLLED STUDY; CYSTECTOMY; FOLLOW UP; HUMAN; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SMOKING; SMOKING CESSATION; SMOKING HABIT; TRANSITIONAL CELL CARCINOMA; TREATMENT OUTCOME;

DOSE RESPONSE; MUSCLE-INVASIVE BLADDER CANCER; PROGRESSION; RADICAL CYSTECTOMY; RECURRENCE; SMOKING; SURVIVAL; UROTHELIAL CARCINOMA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; CYSTECTOMY; DISEASE-FREE SURVIVAL; EUROPE; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LOGISTIC MODELS; LYMPH NODE EXCISION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NORTH AMERICA; ODDS RATIO; RETROSPECTIVE STUDIES; RISK FACTORS; SMOKING; SMOKING CESSATION; TIME FACTORS; TREATMENT OUTCOME; URINARY BLADDER NEOPLASMS;

EID: 84881188874     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2012.11.039     Document Type: Article

References (30)

1. World Health Organization: global health risks. Geneva, Switzerland: WHO Press; 2009.
2. Centers for Disease Control and Prevention. Vital signs: Current cigarette smoking among adults aged >/=18 years - United States, 2005-2010. MMWR Morb Mortal Wkly Rep 2011;60:1207-12.
3. K. Giskes, A.E. Kunst, and J. Benach Trends in smoking behaviour between 1985 and 2000 in nine European countries by education J Epidemiol Community Health 59 2005 395 401
4. N.D. Freedman, D.T. Silverman, A.R. Hollenbeck, A. Schatzkin, and C.C. Abnet Association between smoking and risk of bladder cancer among men and women JAMA 306 2011 737 745
5. S.R. Sturgeon, P. Hartge, and D.T. Silverman Associations between bladder cancer risk factors and tumor stage and grade at diagnosis Epidemiology 5 1994 218 225
6. N. Fleshner, J. Garland, and A. Moadel Influence of smoking status on the disease-related outcomes of patients with tobacco-associated superficial transitional cell carcinoma of the bladder Cancer 86 1999 2337 2345
7. R.J. Lammers, W.P. Witjes, and K. Hendricksen Smoking status is a risk factor for recurrence after transurethral resection of non-muscle-invasive bladder cancer Eur Urol 60 2011 713 720
8. Rink M, Furberg H, Zabor EC, et al. Impact of smoking and smoking cessation on oncologic outcomes in primary non-muscle-invasive bladder cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.08.025.
9. S.A. Strope, and J.E. Montie The causal role of cigarette smoking in bladder cancer initiation and progression, and the role of urologists in smoking cessation J Urol 180 2008 31 37 discussion 37
10. I.M. Thompson, M. Peek, and F.R. Rodriguez The impact of cigarette smoking on stage, grade and number of recurrences of transitional cell carcinoma of the bladder J Urol 137 1987 401 403
11. C.H. Chen, C.T. Shun, and K.H. Huang Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer BJU Int 100 2007 281 286 discussion 286
12. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu Nomograms provide improved accuracy for predicting survival after radical cystectomy Clin Cancer Res 12 2006 6663 6676
13. G. Novara, R.S. Svatek, and P.I. Karakiewicz Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: A multicenter study of more than 4,400 patients J Urol 183 2010 2165 2170
14. Y. Lotan, A. Gupta, and S.F. Shariat Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy J Clin Oncol 23 2005 6533 6539
15. M. Rink, B. Ehdaie, and E.K. Cha Stage-specific impact of tumor location on oncologic outcomes in patients with upper and lower tract urothelial carcinoma following radical surgery Eur Urol 62 2012 677 684
16. S.F. Shariat, P.I. Karakiewicz, and G.S. Palapattu Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: A contemporary series from the Bladder Cancer Research Consortium J Urol 176 2006 2414 2422 discussion 2422
17. M. Rink, H. Fajkovic, and E.K. Cha Death certificates are valid for the determination of cause of death in patients with upper and lower tract urothelial carcinoma Eur Urol 61 2012 854 855
18. R. Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
19. P.J. Bostrom, S. Alkhateeb, and G. Trottier Sex differences in bladder cancer outcomes among smokers with advanced bladder cancer BJU Int 109 2011 70 76
20. J.P. Stein, G. Lieskovsky, and R. Cote Radical cystectomy in the treatment of invasive bladder cancer: Long-term results in 1,054 patients J Clin Oncol 19 2001 666 675
21. X. Jiang, J.E. Castelao, and J.M. Yuan Cigarette smoking and subtypes of bladder cancer Int J Cancer 130 2012 896 901
22. Y. Hirao, W.J. Kim, and K. Fujimoto Environmental factors promoting bladder cancer Curr Opin Urol 19 2009 494 499
23. C.A. Reznikoff, S. Sarkar, and K.P. Julicher Genetic alterations and biological pathways in human bladder cancer pathogenesis Urol Oncol 5 2000 191 203
24. M. Sopori Effects of cigarette smoke on the immune system Nat Rev Immunol 2 2002 372 377
25. S. Begum Molecular changes in smoking-related lung cancer Expert Rev Mol Diagn 12 2012 93 106
26. C.A. Pope III, R.T. Burnett, and M.C. Turner Lung cancer and cardiovascular disease mortality associated with ambient air pollution and cigarette smoke: Shape of the exposure-response relationships Environ Health Perspect 119 2011 1616 1621
27. C.M. Dresler, M.E. Leon, K. Straif, R. Baan, and B. Secretan Reversal of risk upon quitting smoking Lancet 368 2006 348 349
28. M.P. Zeegers, E. Kellen, F. Buntinx, and P.A. van den Brandt The association between smoking, beverage consumption, diet and bladder cancer: A systematic literature review World J Urol 21 2004 392 401
29. T.J. Guzzo, M.S. Hockenberry, P. Mucksavage, T.J. Bivalacqua, and M.P. Schoenberg Smoking knowledge assessment and cessation trends in patients with bladder cancer presenting to a tertiary referral center Urology 79 2012 166 171
30. J.C. Bassett, J.L. Gore, and A.C. Chi Impact of a bladder cancer diagnosis on smoking behavior J Clin Oncol 30 2012 1871 1878